(Q71692731)
Statements
Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of Cancer (English)
P Canal
C Gay
A Dezeuze
J Y Douillard
R Bugat
R Brunet
A Adenis
P Herait
F Lokiec